在受伤暴露的女性样本中,宁- ангиотензин- алдостерон系统的活性
Sinead M Sinnott1, Robyn A Ellis2, Annmarie Khawand3
1Department of Psychiatry, Harvard Medical School, Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Psychiatry research
|June 5, 2025
概括
这项研究发现,女性的氨酸-血管氨酸-氨系统 (RAAS) 和创伤后应激障碍 (PTSD) 之间没有直接联系. 然而,RAAS活性与心血管刺激相关,雌激醇可能会提供对这些影响的保护.
科学领域:
- 神经内分泌学神经内分泌学
- 心理生理学 心理生理学
- 心血管科学 心血管科学
背景情况:
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 与创伤后应激障碍 (PTSD) 和心血管疾病 (CVD) 有关.
- 在PTSD中性别差异可能涉及RAAS和雌激素,一种可能降低RAAS活动的激素.
- 以前的研究表明,在患有PTSD的个体中,RAAS活性较高.
研究的目的:
- 为了复制在PTSD中RAAS活动升高的发现.
- 调查RAAS活动,心理生理激发和创伤暴露的女性中雌激素水平之间的关联.
- 探索雌激醇在调节RAAS-PTSD关系中的潜在作用.
主要方法:
- 招募了37名患有PTSD和创伤暴露的女性参与者.
- 测量的心血管指标:心率 (HR),高频心率变化 (HF-HRV) 和血压 (BP).
- 在恐惧调节过程中通过恐惧强化惊 (FPS) 评估心理生理激发.
主要成果:
- 在PTSD和对照组之间,没有发现雷宁,阿尔多或阿尔多与雷宁比率 (ARR) 的显著差异.
- 较高的氨酸和氨与HR的增加相关;较高的氨酸与更大的FPS大小相关.
- 较高的ARR与较低的HF-HRV相关;这些关联是由雌激醇水平调节的,在低雌激醇组中效果更强.
结论:
- 这项研究没有在这个队列中复制RAAS活动和PTSD之间的直接关联.
- 研究结果表明,RAAS活动与心理生理兴奋标志物有关,可能受到雌激醇的影响.
- 雌激醇可能在RAAS和心血管功能之间的关系中发挥保护作用.
相关概念视频
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Hypertension II: Pathophysiology
91
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
91
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
913
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
913
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
Hormonal Regulation of Blood Pressure
3.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
Antihypertensive Drugs: Direct Renin Inhibitors
849
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
849


